Pacific Biosciences, a US-based gene sequencing company, plans to raise $200m on Nasdaq.
Pacific Biosciences, a US-based gene sequencing company, has provided additional information about its planned $200m flotation on the Nasdaq stock exchange.
In an amended regulatory filing last night Pacific said it would issue 12.5 million shares at between $15 and $17 each to raise $200m at the mid-point of its range and an initial market capitalisation of about $800m.
Existing shareholders, including four strategic investors, are locked-up from selling shares for 180 days and so will be diluted by…
